Kenvue Inc. Common Stock (KVUE)

Kenvue Inc. (NYSEKVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida.

Kenvue Inc. (NYSEKVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero, Ltd., and Erica Mann, former President and Head of Bayer’s Consumer Health Division, to the Company’s Board of Directors (the “Board”). Additionally, Jeffrey Smith, Managing Member, Chief Executive Officer and Chief Investment Officer of Starboard Value LP (together with certain of its affiliates, “Starboard”) will join the Board. All three appointments are effective immediately.

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

These 3 dividend stocks have increased their dividends for over 50 years and are trading at a discounted valuation.

Kenvue Inc. (NYSEKVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available on investors.kenvue.com and a replay will be available on the website following the event.

KVUE earnings call for the period ending December 31, 2024.

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment.

Kenvue Inc. (NYSEKVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024.

Kenvue Inc. (NYSEKVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s (“Starboard”) submission of four nominees to stand for election to the Kenvue Board of Directors at Kenvue’s 2025 Annual Meeting of Shareholders:

Kenvue Inc. (NYSEKVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.

These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.

Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.

Kenvue Inc. (NYSEKVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025.

The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.